-
Something wrong with this record ?
Characteristics of Acinetobacter strains (phenotype classification, antibiotic susceptibility and production of beta-lactamases) isolated from haemocultures from patients at the Teaching Hospital in Olomouc
P. Hejnar, M. Kolár, V. Hájek
Language English Country Czech Republic
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Acinetobacter classification drug effects isolation & purification MeSH
- Anti-Bacterial Agents pharmacology MeSH
- beta-Lactamases biosynthesis MeSH
- beta-Lactams MeSH
- Phenotype MeSH
- Acinetobacter Infections blood microbiology MeSH
- Humans MeSH
- Microbial Sensitivity Tests MeSH
- Hospitals, Teaching MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czech Republic MeSH
A total of 85 strains of the genus Acinetobacter were isolated from haemocultures at the Institute of Microbiology of the Teaching Hospital in Olomouc over the period January 1993 to June 1997. Sixty-two (73.0%) strains of the Acinetobacter calcoaceticus-baumannii complex (Acb complex) were the most frequent. In 3 (3.5%) strains it was impossible to decide whether they belonged to the Acb complex. Other acinetobacter species were represented by 20 (23.5%) strains. The greatest amount (28.2%) of these strains was collected from the Clinic of Internal Medicine. Leukemias, lymphomas and myelodysplastic syndromes were the most frequent clinical diagnoses (20.0%) of the patients with a positive haemoculture. The most effective antimicrobial preparations tested were as follows: meropenem (98.8% of susceptible strains), colistin (94.1%), quinolones (90.6-94.1% according to the type of agent) and amikacin (91.8%). The Acb complex strains were less susceptible to antimicrobial agents than other acinetobacters. Production of inductive chromosomal beta-lactamases AmpC was proved in 42 (49.4%) strains whilst no occurrence of extended-spectrum beta-lactamases (ESBL) in the isolated organisms was recorded.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19007709
- 003
- CZ-PrNML
- 005
- 20190403122957.0
- 007
- ta
- 008
- 190227s1999 xr a f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)10743729
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Hejnar, Petr, $u Institute of Microbiology, Medical Faculty of Palacký University, Olomouc, Czech Republic $d 1966- $7 xx0033714
- 245 10
- $a Characteristics of Acinetobacter strains (phenotype classification, antibiotic susceptibility and production of beta-lactamases) isolated from haemocultures from patients at the Teaching Hospital in Olomouc / $c P. Hejnar, M. Kolár, V. Hájek
- 520 9_
- $a A total of 85 strains of the genus Acinetobacter were isolated from haemocultures at the Institute of Microbiology of the Teaching Hospital in Olomouc over the period January 1993 to June 1997. Sixty-two (73.0%) strains of the Acinetobacter calcoaceticus-baumannii complex (Acb complex) were the most frequent. In 3 (3.5%) strains it was impossible to decide whether they belonged to the Acb complex. Other acinetobacter species were represented by 20 (23.5%) strains. The greatest amount (28.2%) of these strains was collected from the Clinic of Internal Medicine. Leukemias, lymphomas and myelodysplastic syndromes were the most frequent clinical diagnoses (20.0%) of the patients with a positive haemoculture. The most effective antimicrobial preparations tested were as follows: meropenem (98.8% of susceptible strains), colistin (94.1%), quinolones (90.6-94.1% according to the type of agent) and amikacin (91.8%). The Acb complex strains were less susceptible to antimicrobial agents than other acinetobacters. Production of inductive chromosomal beta-lactamases AmpC was proved in 42 (49.4%) strains whilst no occurrence of extended-spectrum beta-lactamases (ESBL) in the isolated organisms was recorded.
- 650 _2
- $a Acinetobacter $x klasifikace $x účinky léků $x izolace a purifikace $7 D000150
- 650 _2
- $a infekce bakteriemi rodu Acinetobacter $x krev $x mikrobiologie $7 D000151
- 650 _2
- $a antibakteriální látky $x farmakologie $7 D000900
- 650 _2
- $a nemocnice fakultní $7 D006784
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a fenotyp $7 D010641
- 650 _2
- $a beta-laktamasy $x biosyntéza $7 D001618
- 650 _2
- $a beta-laktamy $7 D047090
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kolář, Milan, $d 1964- $7 jn20010310083 $u Institute of Microbiology, Medical Faculty of Palacký University, Olomouc, Czech Republic
- 700 1_
- $a Hájek, Václav, $d 1934- $7 jn20000401141 $u Institute of Microbiology, Medical Faculty of Palacký University, Olomouc, Czech Republic
- 773 0_
- $w MED00011326 $t Acta Universitatis Palackianae Olomucensis Facultatis Medicae $x 0862-481X $g Roč. 142, č. 142 (1999), s. 73-77
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/10743729 $y Pubmed
- 856 41
- $u https://biomed.papers.upol.cz/pdfs/bio/1999/01/13.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 1502 $y a $z 0
- 990 __
- $a 20190227 $b ABA008
- 991 __
- $a 20190403123004 $b ABA008
- 999 __
- $a ok $b bmc $g 1380193 $s 1045955
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 1999 $b 142 $c 142 $d 73-77 $i 0862-481X $m Acta Universitatis Palackianae Olomucensis Facultatis medicae. Biomedical papers $n Acta Univ. Palacki. Olomuc. Fac. med., Biomed. Pap. $x MED00011326
- LZP __
- $b NLK118 $a Pubmed-20190227